Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332020 · ClinicalTrials.gov registry record · Phase 3
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,457
- Enrollment target
NCT00332020: Completed Phase 3 study, sponsored by Bayer.
NCT00332020 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 2,457 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (218% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00332020, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,457 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if 10 mg BAY 59-7939, taken once daily as a tablet, is safe and can help prevent blood clots forming after a hip replacement operation.
Interventions
- DRUG Enoxaparin
- DRUG Rivaroxaban (BAY59-7939)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,457 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
What the finished NCT00332020 record still lists
NCT00332020 is an interventional study that assigns participants to a tested intervention. Its 2,457 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (218% higher).
The record links to 0 conditions, and to 2 interventions - of which Enoxaparin is the first listed.
NCT00332020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00332020 about?
NCT00332020 is a clinical study titled "Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement". The purpose of this study is to assess if 10 mg BAY 59-7939, taken once daily as a tablet, is safe and can help prevent blood clots forming after a hip replacement operation.
What is the current status of trial NCT00332020?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,457 participants. The study started on 2006-02. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00332020?
The interventions under investigation include: Enoxaparin (DRUG), Rivaroxaban (BAY59-7939) (DRUG).
Who is sponsoring clinical trial NCT00332020?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00332020's enrollment target sits among peer trials
2,457 88th of 2000 higher than 1,913 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia